Atlas Trials

DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines

Clinical trial NCT00233649 · COMPLETED

Trial details

NCT number
NCT00233649
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes Mellitus Type 2Crestor, RosuvastatinLDL CholesterolObservational
Start date
2004-05-01
Enrollment
2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.